This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

A Safer Way to Play the Drug Sector

02/26/08 - 06:16 AM EST

Contract research organizations aren't without risks of course, but they do offer some protection against the vagaries of the industry.

Shares rise 5.4% on the news.

Reasons to Believe in Schering-Plough

02/11/08 - 02:05 PM EST

Despite the Vytorin setback, the focus here should be on drugs in development, not products in the market.

Big Pharma Moving More Work Offshore

01/25/08 - 02:06 PM EST

Merck, Pfizer and others are getting used to a new world that requires cost discipline.

If a recession can be avoided, 2008, like last year, could be active for initial issues.

Several firms are debating whether to bulk up or shed lower-margin units.

Here's what you need to know about buying these rare, tradition-rich pieces from the Canadian islands.

No Easy Fix for Pfizer

11/29/07 - 02:14 PM EST

It can be done, but it will probably require some tough choices.

Is Mylan Cheap Yet?

11/28/07 - 03:14 PM EST

Shares have dropped more than 30% since May, but questions remain about its model.

Cephalon Still a Stressor

11/06/07 - 04:04 PM EST

Will that change when earnings arrive Thursday?

Page 2 of 147
Top Rated Stocks Top Rated Funds Top Rated ETFs